Oxford Sciences Innovation (OSI) is a science and technology company that has raised £350 million to back research from the Mathematical, Physical and Life Sciences (MPLS) and Medical Sciences divisions of the University of Oxford. In partnership with the University, OSI's primary focus is to provide capital and scaling expertise to spin-out companies.
Parkwalk is one of the UK’s leading technology Enterprise Investment Scheme fund managers, bringing tier-1 investment banking expertise to the EIS sphere. The Parkwalk Technology Funds invest in high-growth knowledge intensive companies with a focus on technology and innovation primarily from UK universities across the growth curve from early stage through to AIM-listed. The Parkwalk managed University of Oxford Isis Funds, first established in 2014, allow alumni and supporters of the University the opportunity to invest in companies formed to commercialise scientific and technological discoveries made at the University of Oxford, in a tax efficient manner through the Enterprise Investment Scheme. For more information, please visit our website.